AMCR vs ELAN · P/E 18, rev $23.51B vs rev $2.74B
Amcor PLC (AMCR) versus Elanco Animal Health (ELAN) — a side-by-side from cached financials, not a winner call.
Amcor PLC (AMCR) is a packaging & containers company listed on US.
Elanco Animal Health (ELAN) is a drug manufacturers - specialty & generic company listed on US.
Latest reported AMCR revenue for 2026-06-30 was $23.51B. Net income was $1.11B. Revenue was up 362.5% from 2025-06-30 to 2026-06-30. AMCR currently screens at market cap $22.52B and trailing P/E 17.6.
Latest reported ELAN revenue for 2026-06-30 was $2.74B. Net income was $111.0M. Revenue was up 99.8% from 2026-03-31 to 2026-06-30. ELAN currently screens at market cap $11.80B.
AMCR currently screens at market cap $22.52B and trailing P/E 17.6. ELAN currently screens at market cap $11.80B.
Not investment advice. Open the AMCR and ELAN stock pages for the full models.
Not investment advice.